Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftazidime PK in CSF: Continuous vs Intermittent
NCT00752882Phase 2Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Modality
- Reversible Covalent Inhibitors
01
Overview
A Phase 2 trial of ceftazidime in Pseudomonas aeruginosa meningitis, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Status: unknown.
02
Drugs
ceftazidime
03
Conditions
Pseudomonas aeruginosa meningitis
Beyond the preview
Go deeper on NCT00752882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00752882.